Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously

Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Haitao Huang, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang, Jingxin Li, Wei Chen, Fengcai Zhu
doi: https://doi.org/10.1101/2022.07.26.22278072

Article usage

Article usage: July 2022 to December 2024

AbstractFullPdf
Jul 20226675375
Aug 202253828325
Sep 20221246333626
Oct 202231919334
Nov 202228124442
Dec 202253315282
Jan 20231682113
Feb 2023109370
Mar 2023200176
Apr 2023139258
May 202394340
Jun 202365544
Jul 202369232
Aug 2023821236
Sep 202399644
Oct 2023100862
Nov 2023611936
Dec 202366324
Jan 2024611043
Feb 202454490
Mar 202474425
Apr 202474528
May 202472317
Jun 20241231341
Jul 2024166943
Aug 2024136426
Sep 2024132645
Oct 2024146630
Nov 2024122430
Dec 20241201
Back to top
Posted July 28, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Haitao Huang, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang, Jingxin Li, Wei Chen, Fengcai Zhu
medRxiv 2022.07.26.22278072; doi: https://doi.org/10.1101/2022.07.26.22278072
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area